The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)-Reference-Cited by-同舟云学术

The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)

Published:2007-04 Issue:1 Volume:83 Page:31-41
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Dearnaley David P.,Sydes Matthew R.,Langley Ruth E.,Graham John D.,Huddart Robert A.,Syndikus Isabel,Matthews John H.L.,Scrase Christopher D.,Jose Chakiath C.,Logue John,Stephens Richard J.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference35 articles.

1. Prostate cancer;Carroll,1996

2. Technological advances in radiotherapy for the treatment of localised prostate cancer;Mangar;Eur J Cancer,2005

3. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial;Dearnaley;Lancet,1999

4. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70Gy with 78Gy for prostate cancer;Pollack;J Clin Oncol,2000

5. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial;Zietman;JAMA,2005

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer;Cochrane Database of Systematic Reviews;2023-03-08

2. Outcomes of radical prostatectomy in treatment of locally advanced prostate cancer: clinical observations;Cancer Urology;2023-02-28

3. Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: 5-Year Efficacy and Toxicity in the DELINEATE Trial;International Journal of Radiation Oncology*Biology*Physics;2023-02

4. The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/β) Ratios in the CHHiP Trial;International Journal of Radiation Oncology*Biology*Physics;2023-02

5. Incidence of genitourinary complications following radiation therapy for localised prostate cancer;World Journal of Urology;2022-08-11